TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/12/24 16:05 | 6/10/24 | IRWD | Ironwood Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | McHugh Julie | MA | D | S | -143 | 6.29 | 0 | -23 | -14 | 140 | D | |||||||||||||||
5/30/24 16:32 | 5/28/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McHugh Julie | MA | D | S | -196 | 78.50 | 0 | -3 | -8 | 29 | D | |||||||||||||||
9/8/22 16:30 | 9/6/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McHugh Julie | MA | D | S | -338 | 78.50 | 0 | -4 | -14 | 26 | D | |||||||||||||||
5/13/22 16:31 | 5/11/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McHugh Julie | MA | D | S | -172 | 57.84 | 0 | -3 | -9 | 31 | D | |||||||||||||||
3/16/22 16:05 | 3/14/22 | IRWD | Ironwood Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | McHugh Julie | MA | D | S | -233 | 11.67 | 0 | -20 | -14 | 118 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |